Efficacy of Microcurrent Therapy for Treatment of Knee Pain

April 17, 2018 updated by: Omron Healthcare Co., Ltd.
The purpose of this study is to evaluate the effect of microcurrent therapy at the knee pain.

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Anticipated)

70

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

21 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Pain perceived as a minimum of 3/10 on a 0-10 pain scale
  • No phobia of electrical stimulation
  • No pain or anti-inflammatory medication will be taken during study
  • Injury that began prior to 6-weeks ago before the onset of pain
  • Grade II soft tissue injury

Exclusion Criteria:

  • Pregnancy
  • Diabetes Mellitus
  • Neuropathy
  • Smoker
  • Uncontrolled HTN
  • Past surgery in the region to be treated by microcurrent
  • Arthritis (RA) in the area to be treated by microcurrent
  • Cardiovascular disease
  • Allergic to tape/electrodes
  • Ligament injury
  • Patella Femoral Pain Syndrome (Anterior knee pain)
  • Dementia
  • Grade III soft tissue injury

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Sham Comparator: control
Device: Microcurrent
Micrucurrent will be apply
Experimental: microcurrent
Device: Microcurrent
Micrucurrent will be apply

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Numeric Pain scale (NRS) for pain (0-10)
Time Frame: 4weeks
4weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Omron Healthcare Co., Ltd.

Collaborators

Elon University, Department of Physical Therapy Education

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2018

Primary Completion (Anticipated)

July 31, 2018

Study Completion (Anticipated)

February 1, 2019

Study Registration Dates

First Submitted

April 17, 2018

First Submitted That Met QC Criteria

April 17, 2018

First Posted (Actual)

April 27, 2018

Study Record Updates

Last Update Posted (Actual)

April 27, 2018

Last Update Submitted That Met QC Criteria

April 17, 2018

Last Verified

April 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • HI794-0001

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Acute Knee Pain

Clinical Trials on Microcurrent

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mauritius

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe